Dynamic levels of extracellular vesicle PD-L1 and complementary radiomics for the prediction of the response to immune checkpoint inhibitors in lung cancer patients.

Rolfo, Cd; De Miguel Perez, D; Russo, A; Murat, Ak; Gunasekaran, M; Manca, P; Peterson, Cb; Mamindla, P; Er, Me; Peddagangireddy, V; Buemi, F; Cooper, B; Hester, L; Hsia, Rc; Cardona, Af; Arrieta, O; Naing, A; Kaushal, S; Serrano, Mj; Colen, Rr.